Epilepsy is one of the more common neurological disorders in the general population, affecting around 50 million people worldwide[1]. It affects 22.2% of people with intellectual disabilities (PwID)[2]. PwID and epilepsy often have seizures that are less well-controlled, of multiple types and are more likely to be resistant to single-drug treatments[3]. This population has increased levels of physical and psychological comorbidity[4–6]. Polypharmacy is common, including psychotropic and anti-seizure medications[4–6].
12
MAR
MAR
0